Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy
- University of Basel, Switzerland
- University of Copenhagen, Denmark
- CNRS, Université Paris Sud, Université Paris-Saclay, France
- ETH Zürich, Switzerland
- Roche Innovation Center Basel, Switzerland
- CNRS, France
- University of Lyon, France
Abstract
Intracellular inclusions rich in alpha-synuclein are a hallmark of several neuropathological diseases including Parkinson's disease (PD). Previously, we reported the structure of alpha-synuclein fibrils (residues 1-121), composed of two protofibrils that are connected via a densely-packed interface formed by residues 50-57 (Guerrero-Ferreira, eLife 218;7:e36402). We here report two new polymorphic atomic structures of alpha-synuclein fibrils termed polymorphs 2a and 2b, at 3.0 Å and 3.4 Å resolution, respectively. These polymorphs show a radically different structure compared to previously reported polymorphs. The new structures have a 10 nm fibril diameter and are composed of two protofilaments which interact via intermolecular salt-bridges between amino acids K45, E57 (polymorph 2a) or E46 (polymorph 2b). The non-amyloid component (NAC) region of alpha-synuclein is fully buried by previously non-described interactions with the N-terminus. A hydrophobic cleft, the location of familial PD mutation sites, and the nature of the protofilament interface now invite to formulate hypotheses about fibril formation, growth and stability.
Data availability
Raw cryo-EM micrographs are available in EMPIAR, entry numbers EMPIAR-10323. The 3D maps are available in the EMDB, entry numbers EMD-10307 (α-Syn polymorph 2a) and EMD-10305 (α-Syn-polymorph 2b). Atomic coordinates are available at the PDB with entry numbers PDB 6SSX (α-Syn polymorph 2a) and PDB 6SST (α-Syn polymorph 2b).
Article and author information
Author details
Ricardo Guerrero-Ferreira
Nicholas MI Taylor
Ana-Andreea Arteni
Funding
Novo Nordisk (NNF14CC0001)
- Nicholas MI Taylor
SERI (17.00038)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
Fondation Bettencourt Schueller
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
fondation pour la Recherche Medicale (Contract DEQ 20160334896)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
Fondation Simone et Cino Del Duca of the Institut de France and
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (TransPathND)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
FRISBI (ANR-10-INSB-05-01)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (ANR-17-JPCD-0005-01)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (ANR-17-JPCD-0002-02)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (Protest-70)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
Synapsis Foundation (n/a)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Heidi-Seiler Stiftung (n/a)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII3_154461)
- Ricardo Guerrero-Ferreira
- Nicholas MI Taylor
- Henning Stahlberg
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII5_177195)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (20020_178792)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Agence Nationale de la Recherche (ANR-12-BS08-0013-01)
- Ronald Melki
- Luc Bousset
LABEX ECOFECT (ANR-11-LABX-0048)
- Anja Böckmann
H2020 (IMPRiND)
- Ana-Andreea Arteni
- Ronald Melki
- Luc Bousset
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2019, Guerrero-Ferreira et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 8,473
- views
-
- 1,283
- downloads
-
- 240
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy
eLife 8:e48907.
https://doi.org/10.7554/eLife.48907
Further reading
-
- Neuroscience
During both sleep and awake immobility, hippocampal place cells reactivate time-compressed versions of sequences representing recently experienced trajectories in a phenomenon known as replay. Intriguingly, spontaneous sequences can also correspond to forthcoming trajectories in novel environments experienced later, in a phenomenon known as preplay. Here, we present a model showing that sequences of spikes correlated with the place fields underlying spatial trajectories in both previously experienced and future novel environments can arise spontaneously in neural circuits with random, clustered connectivity rather than pre-configured spatial maps. Moreover, the realistic place fields themselves arise in the circuit from minimal, landmark-based inputs. We find that preplay quality depends on the network’s balance of cluster isolation and overlap, with optimal preplay occurring in small-world regimes of high clustering yet short path lengths. We validate the results of our model by applying the same place field and preplay analyses to previously published rat hippocampal place cell data. Our results show that clustered recurrent connectivity can generate spontaneous preplay and immediate replay of novel environments. These findings support a framework whereby novel sensory experiences become associated with preexisting “pluripotent” internal neural activity patterns.
-
- Developmental Biology
- Neuroscience
A finely tuned balance between excitation and inhibition (E/I) is essential for proper brain function. Disruptions in the GABAergic system, which alter this equilibrium, are a common feature in various types of neurological disorders, including autism spectrum disorders (ASDs). Mutations in Phosphatase and Tensin Homolog (PTEN), the main negative regulator of the phosphatidylinositol 3-phosphate kinase/Akt pathway, are strongly associated with ASD. However, it is unclear whether PTEN deficiencies can differentially affect inhibitory and excitatory signaling. Using the Caenorhabditis elegans neuromuscular system, where both excitatory (cholinergic) and inhibitory (GABAergic) inputs regulate muscle activity, we found that daf-18/PTEN mutations impact GABAergic (but not cholinergic) neurodevelopment and function. This selective impact results in a deficiency in inhibitory signaling. The defects observed in the GABAergic system in daf-18/PTEN mutants are due to reduced activity of DAF-16/FOXO during development. Ketogenic diets (KGDs) have proven effective for disorders associated with E/I imbalances. However, the mechanisms underlying their action remain largely elusive. We found that a diet enriched with the ketone body β-hydroxybutyrate during early development induces DAF-16/FOXO activity, therefore improving GABAergic neurodevelopment and function in daf-18/PTEN mutants. Our study provides valuable insights into the link between PTEN mutations and neurodevelopmental defects and delves into the mechanisms underlying the potential therapeutic effects of KGDs.
